<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2021, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 25 Feb 2021 09:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years</title>
   <link>http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</guid>
   <pubDate>Thu, 25 Feb 2021 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41792313</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years</title>
   <link>http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</guid>
   <pubDate>Thu, 25 Feb 2021 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41792313</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years</title>
   <link>http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</guid>
   <pubDate>Thu, 25 Feb 2021 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41792313</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years</title>
   <link>http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</guid>
   <pubDate>Thu, 25 Feb 2021 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41792313</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years</title>
   <link>http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</guid>
   <pubDate>Thu, 25 Feb 2021 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41792313</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years</title>
   <link>http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</guid>
   <pubDate>Thu, 25 Feb 2021 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41792313</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years</title>
   <link>http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</guid>
   <pubDate>Thu, 25 Feb 2021 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41792313</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years</title>
   <link>http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</guid>
   <pubDate>Thu, 25 Feb 2021 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41792313</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years</title>
   <link>http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</guid>
   <pubDate>Thu, 25 Feb 2021 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41792313</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years</title>
   <link>http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Aimmune+Presents+New+Clinical+Data+From+Pooled+Safety+Analysis+in+Patients+Treated+With+PALFORZIA%C2%AE+for+up+to+%7E3.5+Years/18033040.html</guid>
   <pubDate>Thu, 25 Feb 2021 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41792313</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>European Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EU</title>
   <link>http://www.streetinsider.com/Press+Releases/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html</guid>
   <pubDate>Mon, 21 Dec 2020 01:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36331922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>European Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EU</title>
   <link>http://www.streetinsider.com/Press+Releases/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html</guid>
   <pubDate>Mon, 21 Dec 2020 01:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36331922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>European Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EU</title>
   <link>http://www.streetinsider.com/Press+Releases/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html</guid>
   <pubDate>Mon, 21 Dec 2020 01:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36331922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>European Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EU</title>
   <link>http://www.streetinsider.com/Business+Wire/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html</guid>
   <pubDate>Mon, 21 Dec 2020 01:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36331922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>European Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EU</title>
   <link>http://www.streetinsider.com/Business+Wire/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html</guid>
   <pubDate>Mon, 21 Dec 2020 01:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36331922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>European Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EU</title>
   <link>http://www.streetinsider.com/Business+Wire/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/European+Commission+Approves+Aimmune%E2%80%99s+PALFORZIA%C2%AE+as+First-Ever+Treatment+for+Peanut+Allergy+in+the+EU/17741572.html</guid>
   <pubDate>Mon, 21 Dec 2020 01:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36331922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Form  15-12B     Aimmune Therapeutics,                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++Aimmune+Therapeutics%2C++++++++++++++++/17506198.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++Aimmune+Therapeutics%2C++++++++++++++++/17506198.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++Aimmune+Therapeutics%2C++++++++++++++++/17506198.html</guid>
   <pubDate>Fri, 23 Oct 2020 13:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Form  8-K        Aimmune Therapeutics,     For: Oct 13</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+13/17485581.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+13/17485581.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+13/17485581.html</guid>
   <pubDate>Mon, 19 Oct 2020 17:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Form  4          Aimmune Therapeutics,     For: Oct 13  Filed by: Societe des Produits Nestle S.A.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+13++Filed+by%3A+Societe+des+Produits+Nestle+S.A./17475496.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+13++Filed+by%3A+Societe+des+Produits+Nestle+S.A./17475496.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+13++Filed+by%3A+Societe+des+Produits+Nestle+S.A./17475496.html</guid>
   <pubDate>Thu, 15 Oct 2020 19:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Form  EFFECT     Aimmune Therapeutics,                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Aimmune+Therapeutics%2C++++++++++++++++/17471109.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Aimmune+Therapeutics%2C++++++++++++++++/17471109.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Aimmune+Therapeutics%2C++++++++++++++++/17471109.html</guid>
   <pubDate>Thu, 15 Oct 2020 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Form  EFFECT     Aimmune Therapeutics,                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Aimmune+Therapeutics%2C++++++++++++++++/17471068.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Aimmune+Therapeutics%2C++++++++++++++++/17471068.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Aimmune+Therapeutics%2C++++++++++++++++/17471068.html</guid>
   <pubDate>Thu, 15 Oct 2020 06:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Form  4          Aimmune Therapeutics,     For: Oct 10  Filed by: Dallas Jayson Donald Alexander</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+10++Filed+by%3A+Dallas+Jayson+Donald+Alexander/17469410.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+10++Filed+by%3A+Dallas+Jayson+Donald+Alexander/17469410.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+10++Filed+by%3A+Dallas+Jayson+Donald+Alexander/17469410.html</guid>
   <pubDate>Wed, 14 Oct 2020 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Form  4          Aimmune Therapeutics,     For: Oct 10  Filed by: BJERKHOLT ERIC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+10++Filed+by%3A+BJERKHOLT+ERIC/17469409.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+10++Filed+by%3A+BJERKHOLT+ERIC/17469409.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+10++Filed+by%3A+BJERKHOLT+ERIC/17469409.html</guid>
   <pubDate>Wed, 14 Oct 2020 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
  <item>
   <title>Form  4          Aimmune Therapeutics,     For: Oct 10  Filed by: Seltzer Stacey Denenberg</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+10++Filed+by%3A+Seltzer+Stacey+Denenberg/17469408.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+10++Filed+by%3A+Seltzer+Stacey+Denenberg/17469408.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aimmune+Therapeutics%2C+++++For%3A+Oct+10++Filed+by%3A+Seltzer+Stacey+Denenberg/17469408.html</guid>
   <pubDate>Wed, 14 Oct 2020 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIMT</category>
   	  </item>
 </channel>
</rss>
